SERNYSE United States
Market cap
$35.994 M
$2.40 +2.13%
Close of 7 Aug 2026
Revenue
$130.0K
#3603 by revenue
Earnings
-$19.2M
Loss-making
Shares outstanding
12,314,159
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Serina Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.